Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Herman Chui

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Pathology|January 7, 2026
ERBB2 amplification is a late event in the pathogenesis of high-grade endometrial carcinomas with heterogeneous HER2 expressionMichael Herman Chui, David N Brown, Jorge S Reis-Filho, et al.
Archives of Pathology & Laboratory Medicine|August 24, 2016
Histopathologic Features of Prognostic Significance in High-Grade OsteosarcomaMichael Herman Chui, Rita A Kandel, Marcus Wong, et al.
The Journal of Pathology|December 17, 2013
Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancyRen-Chin Wu, Ayse Ayhan, Daichi Maeda, et al.
The American Journal of Surgical Pathology|July 26, 2019
Clinicopathologic and Molecular Features of Paired Cases of Metachronous Ovarian Serous Borderline Tumor and Subsequent Serous CarcinomaMichael Herman Chui, Deyin Xing, Felix Zeppernick, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
In-depth molecular profiling of the biphasic components of uterine carcinosarcomasMelissa K McConechy, Lien N Hoang, Michael Herman Chui, et al.
The American Journal of Surgical Pathology|July 16, 2014
The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategyMichael Herman Chui, Paul Ryan, Jordan Radigan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 27, 2018
Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung CarcinomaHui Yu, Zhengming Chen, Karla V Ballman, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Pathology|January 7, 2026
ERBB2 amplification is a late event in the pathogenesis of high-grade endometrial carcinomas with heterogeneous HER2 expressionMichael Herman Chui, David N Brown, Jorge S Reis-Filho, et al.
Archives of Pathology & Laboratory Medicine|August 24, 2016
Histopathologic Features of Prognostic Significance in High-Grade OsteosarcomaMichael Herman Chui, Rita A Kandel, Marcus Wong, et al.
The Journal of Pathology|December 17, 2013
Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancyRen-Chin Wu, Ayse Ayhan, Daichi Maeda, et al.
The American Journal of Surgical Pathology|July 26, 2019
Clinicopathologic and Molecular Features of Paired Cases of Metachronous Ovarian Serous Borderline Tumor and Subsequent Serous CarcinomaMichael Herman Chui, Deyin Xing, Felix Zeppernick, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
In-depth molecular profiling of the biphasic components of uterine carcinosarcomasMelissa K McConechy, Lien N Hoang, Michael Herman Chui, et al.
The American Journal of Surgical Pathology|July 16, 2014
The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategyMichael Herman Chui, Paul Ryan, Jordan Radigan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 27, 2018
Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung CarcinomaHui Yu, Zhengming Chen, Karla V Ballman, et al.
Pageof 2